JUST IN: Novo Nordisk said the partnership with OpenAI aims to bring new and better treatments to patients faster.


The Danish pharmaceutical company wants to use AI to analyze complex data, identify promising drugs, and accelerate the transition from research to clinical use.
post-image
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin